Covered entities may not use identifiable patient information, including names, faces, conditions or review details, in marketing or social content without the patient's HIPAA authorization.
What is Unauthorized Health Information Marketing Use?
Covered entities may not use identifiable patient information, including names, faces, conditions or review details, in marketing or social content without the patient's HIPAA authorization. Use for covered-entity testimonials, patient stories, case studies, before-and-after images, social posts and replies to online reviews.
patients, general_audience, general_adults_18plus, customers · Healthcare Services, Telehealth, Specialty Clinics, Hospitals Health Systems, Health Insurance · healthcare
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
Covered entities may not use identifiable patient information, including names, faces, conditions or review details, in marketing or social content without the patient's HIPAA authorization.
How can marketing teams comply?
Use for covered-entity testimonials, patient stories, case studies, before-and-after images, social posts and replies to online reviews.
What is Unauthorized Health Information Marketing Use?
Covered entities may not use identifiable patient information, including names, faces, conditions or review details, in marketing or social content without the patient's HIPAA authorization.
Who does this rule apply to?
patients, general_audience, general_adults_18plus, customers · Healthcare Services, Telehealth, Specialty Clinics, Hospitals Health Systems, Health Insurance · healthcare
Marketing of open banking or account-linking must not misstate how long data is accessed, how it is used, or the consumer's ability to stop sharing; the 2024 Section 1033 rule is enjoined and under reconsideration, so only facially misleading claims are checked.
Requires businesses covered by the Connecticut Data Privacy Act to publish a privacy notice with required content, offer opt-outs for sale and targeted advertising, and get opt-in consent for sensitive data.
Before collecting face geometry, voiceprints or fingerprints from Illinois residents, a business must give written notice of the collection, its purpose and retention period, obtain a written release, and never sell or profit from the data.
Under the Maryland Online Data Privacy Act, controllers may not sell sensitive data at all, may collect it only when strictly necessary for a requested product or service, may not use or sell the personal data of consumers they know or should know are under 18 for targeted advertising, and must clearly and conspicuously disclose sale and targeted advertising and how to opt out.
Controllers covered by New Hampshire's privacy law must clearly and conspicuously disclose any sale of personal data or targeted advertising, provide a clear and conspicuous website opt-out link, honor opt-out preference signals, and get consent before processing sensitive data or using a known 13-15-year-old's data for targeted ads or sale.
Nevada's consumer health data law requires affirmative consent to collect consumer health data, separate consent to share it, written authorization to sell it, a consumer health data privacy policy linked from the main website, and bans geofences within 1,750 feet of health care facilities used to track, collect data from or send health-related ads to consumers.
Request a free compliance scan of your homepage and book a time with Warrant.